InvestorsHub Logo
Followers 5
Posts 486
Boards Moderated 0
Alias Born 05/03/2005

Re: andranigian post# 6954

Tuesday, 04/30/2019 4:55:06 PM

Tuesday, April 30, 2019 4:55:06 PM

Post# of 7536
Good results. 34% Revenue increase. 81% gross margins staying the same. Now they will be hiring reps even faster this year - at a pace of 10 per month. A questioner asked how much of the gap left by the previous competitor has been reclaimed and Sandgaard said in the 10s of millions not in the 100s of millions that was left. They are tentatively looking at some acquisitions in a complementary space. He said they have a great training process now for new reps, and the new marketing materials are just about to be deployed to the sales reps. He also mentioned that they could be included in the Russell 2000 soon. They continue to have some clinical studies to prove the efficacy of their new blood volume monitor.

I think the stock continues to look good. They are really building out a strong salesforce and I think they could continue to grow even after fully filling the void from the previous competitor by acquiring other complementary products.

This is their weakest quarter and they still improved 4% over last quarter.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYXI News